| Wissenschaftl. Titel | A Phase 1 First-in-Human Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR441000 Administered Intratumorally as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors |
| Erkrankung |
Solide Tumore/Neoplasien:
Verschiedene solide Tumore/Neoplasien:
Alle Linien
|
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (NIH) Weiterführende Informationen (EudraCT) |
erstellt 28.10.2019 Data entry X CCP
geändert 29.12.2023 Data entry III CCP